share_log

宣泰医药(688247.SH):公司产品参与国家组织药品集中带量采购拟中选

Xuantai Pharmaceutical (688247.SH): The company's products are participating in the national organization for centralized volume-based procurement of Pharmaceuticals and are expected to be selected.

Gelonghui Finance ·  Dec 13 18:00

On December 13, 2023, GLONGLON announced that Xuantai Pharmaceutical (688247.SH) participated in the bidding for the tenth batch of national organized Pharmaceutical centralized volume procurement. According to the document "Public Announcement of the Proposed Selection Results for National Centralized Pharmaceutical Procurement" published by the National Organized Pharmaceutical Joint Procurement Office on December 12, 2024, the company's products, Seviram Carbonate Tablets and Macitentan Tablets (products developed in cooperation with Puji Biotechnology (Taizhou) Co., Ltd.), were selected for this centralized volume procurement, while Posaconazole enteric-coated tablets and Tofacitinib citrate extended-release tablets were not selected for this centralized volume procurement. The selection results of this centralized volume procurement are expected to be implemented in April 2025, with specific execution dates subject to notifications issued by local authorities.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment